ARTICLE SUMMARY:
Recent surveys of hospital purchasing managers suggest pricing pressure on high-cost implantable devices may be easing a bit as hospitals turn their attention to downstream (post-op) cost-control efforts, particularly as bundled-payment programs begin to take hold.
According to a recent Needham and Company survey of 54 hospital purchasing managers, US hospitals continue to push for cost reductions in high-priced implantable devices, with hip and knee implants and cardiac rhythm management (CRM) devices at the top of the list of current cost-control efforts.
